Gsk (GSK) EBIAT (2009 - 2026)
Gsk (GSK) posted EBIAT of $6.1 million for Q4 2015.
Gsk (GSK) has 1 years of EBIAT data on file, last reported at $6.1 million in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 7.40 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 5.24 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 697.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -4.24 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 1.82 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 2.02 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 2.71 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 2.68 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.48 Bn |
| Dec 31, 2025 | 967.03 Mn |
| Sep 30, 2025 | 3.31 Bn |
| Jun 30, 2025 | 2.52 Bn |
| Mar 31, 2025 | 2.23 Bn |
| Dec 31, 2024 | 3.06 Bn |
| Sep 30, 2024 | 83.16 Mn |
| Jun 30, 2024 | 1.89 Bn |
| Mar 31, 2024 | 1.37 Bn |
| Dec 31, 2023 | 4.19 Bn |
| Sep 30, 2023 | 2.27 Bn |
| Jun 30, 2023 | 2.49 Bn |
| Mar 31, 2023 | 1.98 Bn |
| Dec 31, 2022 | 2.95 Bn |
| Sep 30, 2022 | 1.19 Bn |
| Jun 30, 2022 | 1.13 Bn |
| Mar 31, 2022 | 2.38 Bn |
| Dec 31, 2021 | 2.90 Bn |
| Sep 30, 2021 | 1.89 Bn |
| Jun 30, 2021 | 2.15 Bn |
| Mar 31, 2021 | 1.74 Bn |
| Dec 31, 2020 | -4.66 Bn |
| Sep 28, 2020 | 5.21 Bn |
| Jun 30, 2020 | 3.28 Bn |
| Mar 31, 2020 | 2.15 Bn |
| Dec 31, 2019 | 2.62 Bn |
| Sep 30, 2019 | 2.12 Bn |
| Jun 30, 2019 | 1.63 Bn |
| Mar 31, 2019 | 1.28 Bn |
| Dec 31, 2018 | 1.59 Bn |
| Sep 30, 2018 | 2.22 Bn |
| Jun 30, 2018 | 836.49 Mn |
| Mar 31, 2018 | 1.06 Bn |
| Dec 31, 2017 | 1.51 Bn |
| Sep 30, 2017 | 1.95 Bn |
| Jun 30, 2017 | -230.01 Mn |
| Mar 31, 2017 | 1.51 Bn |
| Dec 31, 2016 | 820.53 Mn |
| Sep 30, 2016 | 1.16 Bn |
| Jun 30, 2016 | -706.61 Mn |
| Mar 31, 2016 | 504.52 Mn |
| Dec 31, 2015 | 6.07 Mn |
| Sep 30, 2015 | 1.34 Bn |
| Jun 30, 2015 | 232.65 Mn |
| Mar 31, 2015 | 12.19 Bn |
| Dec 31, 2014 | 2.25 Bn |
| Sep 30, 2014 | 643.57 Mn |
| Jun 30, 2014 | 1.66 Bn |
| Mar 31, 2014 | 1.19 Bn |
| Dec 31, 2013 | 3.42 Bn |
| Sep 30, 2013 | 1.57 Bn |
| Jun 30, 2013 | 1.98 Bn |
| Mar 31, 2013 | 1.60 Bn |
| Dec 31, 2012 | 4.30 Bn |
| Sep 30, 2012 | 2.35 Bn |
| Jun 30, 2012 | 2.42 Bn |
| Mar 31, 2012 | 2.16 Bn |
| Dec 31, 2011 | 2.02 Bn |
| Sep 30, 2011 | 3.13 Bn |
| Jun 30, 2011 | 2.60 Bn |
| Mar 31, 2011 | 2.54 Bn |
| Dec 31, 2010 | -1.00 Bn |
| Sep 30, 2010 | 2.08 Bn |
| Jun 30, 2010 | -882.16 Mn |
| Mar 31, 2010 | 2.18 Bn |
| Dec 31, 2009 | 2.72 Bn |
| Sep 30, 2009 | 2.25 Bn |
| Jun 30, 2009 | 3.48 Bn |
| Mar 31, 2009 | 1.68 Bn |